Overview

Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult Volunteers

Status:
Not yet recruiting

Trial end date:
2023-09-15

Target enrollment:

Participant gender:

Summary

The objective of this study is to assess the oral bioavailability of crushed and ground venetoclax commercial tablets relative to the intact venetoclax commercial tablets under fed condition in healthy female participants.

Phase:

Phase 1

Details

Lead Sponsor:

AbbVie

Treatments:

Venetoclax